Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

(Bloomberg) -- A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s ...

Pfizer sued Novo Nordisk, Metsera and Metsera's controlling shareholders on Oct. 31 in Delaware Court of Chancery in relation to Pfizer's proposed acquisition of Metsera, an obesity treatment maker.

Key takeaways from Supreme Court arguments on Nov. 5 over the legality of the Trump administration’s reciprocal and fentanyl-linked tariffs led Bloomberg Intelligence’s Votes and Verdicts podcast this ...

Pfizer delivered a significant earnings surprise in its third-quarter results, demonstrating the pharmaceutical giant’s resilience amid a challenging year for its stock performance. The company’s ...

On July 30, 2025, the U.S. District Court for the District of Delaware entered a Final Judgment in the dispute between Alnylam Pharmaceuticals, Inc. (“Alnylam”) and Pfizer, Inc. (“Pfizer”)—concluding ...